Eversept Partners, LP Deciphera Pharmaceuticals, Inc. Transaction History

Eversept Partners, LP

$1.29 Billion
Q3 2025

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$32.73 - $47.95 $11.3 Million - $16.6 Million	-345,717 Closed	0 $0
Q1 2021 Nov 08, 2023	BUY	$40.39 - $56.73 $4.02 Million - $5.64 Million	99,477 Added 40.4%	345,717 $15.5 Million
Q1 2021 May 13, 2021	BUY	$40.39 - $56.73 $4.02 Million - $5.64 Million	99,477 Added 40.4%	345,717 $15.5 Million
Q4 2020 Nov 08, 2023	BUY	$51.77 - $66.18 $12.7 Million - $16.3 Million	246,240 New	246,240 $14.1 Million
Q4 2020 Feb 16, 2021	SELL	$51.77 - $66.18 $8.09 Million - $10.3 Million	-156,193 Reduced 38.81%	246,240 $14.1 Million

Q3 2020 Nov 08, 2023	SELL	$43.8 - $58.16 $710,392 - $943,297	-16,219 Reduced 3.87%	402,433 $20.6 Million
Q3 2020 Nov 13, 2020	SELL	$43.8 - $58.16 $710,392 - $943,297	-16,219 Reduced 3.87%	402,433 $20.6 Million
Q2 2020 Nov 08, 2023	BUY	$37.05 - $65.03 $169,355 - $297,252	4,571 Added 1.1%	418,652 $25 Million
Q2 2020 Aug 13, 2020	BUY	$37.05 - $65.03 $169,355 - $297,252	4,571 Added 1.1%	418,652 $25 Million
Q1 2020 Nov 08, 2023	BUY	$33.63 - $69.4 $9.6 Million - $19.8 Million	285,333 Added 221.62%	414,081 $17 Million
Q1 2020 May 13, 2020	BUY	$33.63 - $69.4 $9.6 Million - $19.8 Million	285,333 Added 221.62%	414,081 $17 Million
Q4 2019 Nov 08, 2023	BUY	$31.7 - $69.93 $3.38 Million - $7.46 Million	106,748 Added 485.22%	128,748 $8.01 Million
Q4 2019 Feb 13, 2020	BUY	$31.7 - $69.93 $3.38 Million - $7.46 Million	106,748 Added 485.22%	128,748 $8.01 Million
Q3 2019 Nov 08, 2023	SELL	$19.95 - $38.85 $5.65 Million - $11 Million	-283,233 Reduced 92.79%	22,000 $746,000
Q3 2019 Nov 13, 2019	SELL	$19.95 - $38.85 $5.65 Million - $11 Million	-283,233 Reduced 92.79%	22,000 $747,000
Q2 2019 Nov 08, 2023	BUY	$21.05 - $26.21 $1.15 Million - $1.44 Million	54,801 Added 21.88%	305,233 $6.88 Million
Q2 2019 Aug 13, 2019	BUY	$21.05 - $26.21 $1.15 Million - $1.44 Million	54,801 Added 21.88%	305,233 $6.88 Million
Q1 2019 Nov 08, 2023	BUY	$20.65 - $29.55 $3.73 Million - $5.34 Million	180,732 Added 259.3%	250,432 $5.81 Million
Q1 2019 May 14, 2019	BUY	$20.65 - $29.55 $3.73 Million - $5.34 Million	180,732 Added 259.3%	250,432 $5.81 Million
Q4 2018 Nov 08, 2023	BUY	$19.08 - $36.14 $1.15 Million - $2.17 Million	60,164 Added 630.91%	69,700 $1.46 Million
Q4 2018 Feb 13, 2019	BUY	$19.08 - $36.14 $1.33 Million - $2.52 Million	69,700 New	69,700 $1.46 Million
Q3 2018 Nov 14, 2018	SELL	$33.57 - $42.1 $320,123 - $401,465	-9,536 Closed	0 $0
Q2 2018 Nov 08, 2023	SELL	$20.06 - $44.95 $1.52 Million - $3.4 Million	-75,554 Reduced 88.79%	9,536 $375,000
Q2 2018 Aug 14, 2018	SELL	$20.06 - $44.95 $1.52 Million - $3.4 Million	-75,554 Reduced 88.79%	9,536 $375,000
Q1 2018 Nov 08, 2023	BUY	$20.04 - $29.71 $1.71 Million - $2.53 Million	85,090 New	85,090 $1.71 Billion
Q1 2018 May 14, 2018	BUY	$20.04 - $29.71 $1.71 Million - $2.53 Million	85,090 New	85,090 $1.71 Million

Others Institutions Holding DCPH

# of Institutions

Shares Held

212K

Call Options Held

500

Put Options Held

View Full List

About Deciphera Pharmaceuticals, Inc.

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

More about DCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.

Account